← Leaderboards
Alison J. Quayle
Brigham And Women'S Hospital
$3,973,361
Attributed
$6,778,498
Total exposure
7
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $611.2K · FY2005–20$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$6,778,498 · 7
By mechanism
R01$4,717,508 · 3
U19$1,670,490 · 2
R21$390,500 · 1
P01$0 · 1
Top collaborators
- Ashok A Aiyar6 shared
- Danny J Schust4 shared
- Christopher Michael Taylor4 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Celia Byrne$2,606,449
- Stacey Ann Missmer$8,921,131
- Ursula B Kaiser$24,940,274
- Neil W Toribara$0
- Jeffrey Pudney$0
Others in their field
Top investigators on “Infection”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,939,185
- Lawrence Corey · Fred Hutchinson Cancer Center$789,608,171
- Judith S. Currier · University Of California Los Angeles$511,038,212
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$463,711,983
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$415,229,497
Research focus
InfectionWomanEndocervixMediatingImmune ResponseEpithelial CellsReproductiveChlamydia TrachomatisEpitheliumSiteFemaleImmuneCytokineResponsePathway InteractionsCellsPhysiologicalGenital SystemIn VivoClinical ResearchChronicIn VitroEventEpithelial
Grant awards (21)
Consequences of vaginal microbiota on IFNÃÂó-mediated clearance of Chlamydia trachomatis$611,183
R01 · FY2020 · AI · contact PI
Consequences of vaginal microbiota on IFNγ-mediated clearance of Chlamydia trachomatis$608,392
R01 · FY2019 · AI · contact PI
Consequences of vaginal microbiota on IFNγ-mediated clearance of Chlamydia trachomatis$600,550
R01 · FY2018 · AI · contact PI
Consequences of vaginal microbiota on IFNγ-mediated clearance of Chlamydia trachomatis$608,095
R01 · FY2017 · AI · contact PI
Prevention of HIV transmission/acquisition through informed contraceptive choice$391,789
R01 · FY2016 · AI · contact PI
Prevention of HIV transmission/acquisition through informed contraceptive choice$600,010
R01 · FY2015 · AI · contact PI
Prevention of HIV transmission/acquisition through informed contraceptive choice$499,148
R01 · FY2014 · AI · contact PI
Prevention of HIV transmission/acquisition through informed contraceptive choice$491,200
R01 · FY2013 · AI · contact PI
NOVEL CELLULAR & GENETIC ANALYSES USING A NEW CHLAMYDIA PENETRANT PEPTIDE$177,500
R21 · FY2012 · AI
NOVEL CELLULAR & GENETIC ANALYSES USING A NEW CHLAMYDIA PENETRANT PEPTIDE$213,000
R21 · FY2011 · AI
Cervical T Cell Immunity to C. trachomatis$143,022
U19 · FY2009 · AI · contact PI
Cervical T Cell Immunity to C. trachomatis$293,237
U19 · FY2008 · AI · contact PI
Cervical T Cell Immunity to C. trachomatis$429,080
U19 · FY2007 · AI · contact PI
Cervical T cell immunity to Chlamydia trachomatis$93,140
U19 · FY2007 · AI · contact PI
Cervical T Cell Immunity to C. trachomatis$240,026
U19 · FY2006 · AI · contact PI
Cervical T Cell Immunity to C. trachomatis$237,948
U19 · FY2005 · AI
Cervical T Cell Immunity to C. trachomatis$234,037
U19 · FY2004 · AI
EPITHELIAL DEFENSINS IN MALE GENITAL TRACT$0
P01 · FY2002 · AI
HUMAN DEFENSIN-5 IN FEMALE GENITAL TRACT IMMUNE DEFENSE$142,804
R01 · FY2001 · AI
HUMAN DEFENSIN-5 IN FEMALE GENITAL TRACT IMMUNE DEFENSE$164,337
R01 · FY2000 · AI
EPITHELIAL DEFENSINS IN MALE GENITAL TRACT$0
P01 · FY2000 · AI